Stay updated on AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Sign up to get notified when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.

Latest updates to the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNo significant changes to the study record content; the two screenshots show the same sections with only minor layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check41 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check48 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

- Check62 days agoChange DetectedUpdated page revision to v3.0.2; removed v3.0.1 and the 'Back to Top' link.SummaryDifference0.1%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.1%

- Check76 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and specific locations, while removing redundant location terms. Additionally, a new reference related to antioxidant supplements has been included.SummaryDifference3%

Stay in the know with updates to AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Enter your email address, and we'll notify you when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.